The agency hasn’t previously been able to track medical device shortages, as devicemakers aren’t required to report shortages the way drugmakers are.
But a section of the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, requires manufacturers to tell the FDA of any interruptions in the supply chain of medical devices that are likely to affect U.S. hospitals’ ability to treat COVID-19 patients.
The rule will only be in effect while the pandemic is considered a public health emergency in the U.S., according to the FDA.
Read the full news release here.
More articles on supply chain:
ICE working with Amazon, Pfizer to keep fake COVID-19 supplies out of US
FDA tightens standards for COVID-19 antibody tests
LabCorp furloughs employees
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
